Matt Handel, CEO, ExpressCells
Matt Handel is the CEO of ExpressCells, a genetic engineering company based in Philadelphia. He is also a Board Director of PolyAurum, LLC, an oncology company.
Matt is a life sciences entrepreneur, executive and board director who previously led Recensa Therapeutics and Skyran Biologics. Matt’s areas of expertise include marketing, executive management, licensing and acquisitions, investment, and government relations, both in the U.S. and globally. Matt began his career at Merck & Co. and then spent 11 years at Shire Pharmaceuticals in business development, business intelligence and product leadership.
Matt earned his M.S. from the MIT Sloan School of Management and his B.A. from Princeton University. He sits on several non-profit Boards that support human services in the Philadelphia area. In his younger days, Matt was a three-day champion on the television show Jeopardy.